Three insights:
1. IDCT is an injectable cell therapy that use progenitor cells — known as Discogenic Cells — to provide a regenerative solution for the treatment of mild to moderate degenerative disc disease.
2. Its biomedically engineered progenitor cells are derived from intervertebral disc tissue and offer a non-invasive approach to treating the condition.
3. IDCT is currently being evaluated in clinical trials in the U.S. and Japan.
More articles on devices:
Colorado health system building orthopedic, sports medicine practice
Aurora Spine posts $3.2M in Q2 revenue: 6 things to know
Dr. Thomas Parisi, patient travel to Mexico for total knee replacement where it costs $18,000 less
